ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
72 hedge funds and large institutions have $203M invested in ChemoCentryx, Inc. in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
29% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 17
25% more capital invested
Capital invested by funds: $163M → $203M (+$40M)
11% more funds holding
Funds holding: 65 → 72 (+7)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
52% less call options, than puts
Call options by funds: $293K | Put options by funds: $615K
Top Buyers
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$6.34M |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.95M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$3.1M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$1.71M |
| 5 |
EAM
EverPoint Asset Management
Stamford,
Connecticut
|
-$1.24M |
CCXI Hedge Fund Activity: Q4 2015 in Review
72 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q4 2015, worth a combined $203M — up 25% from $163M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new CCXI positions and 4 closed out — a net gain of 7 holders — while 22 added to existing stakes and 17 trimmed.
The largest buyer was Credit Suisse, adding an estimated $2.69M. The largest seller was BVF Inc, cutting an estimated $6.34M.
- 72 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q4 2015, up from 65 in Q3 2015.
- Funds reported $203M of ChemoCentryx, Inc. stock for Q4 2015, up 25% quarter-over-quarter.
- 11 funds opened new ChemoCentryx, Inc. positions in Q4 2015 and 4 closed out, a net change of +7 holders.
- The largest ChemoCentryx, Inc. buyer in Q4 2015 was Credit Suisse, an estimated $2.69M added.
- The largest ChemoCentryx, Inc. seller in Q4 2015 was BVF Inc, an estimated $6.34M sold.
Based on aggregated 13F filings for Q4 2015.